# Symbicort in Chronic Obstructive Pulmonary Disease

> **NCT00611520** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 64730 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00611520
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-12
- **Final completion:** —
- **Target enrollment:** 64730 (ACTUAL)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611520, "Symbicort in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00611520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*